Real World Experience Idelalisib – Rituximab Combination for Relapsed CLL

Jennifer R. Brown, MD Director, Chronic Lymphocytic Leukemia Center Dana-Farber Cancer Institute talks about Real World Experience with Idelalisib – Rituximab Combination for Relapsed CLL